Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131893) titled 'Randomized Controlled Trial: Aprepitant plus Ondansetron to Prevent PONV after Thyroidectomy' on Sept. 7.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second People's Hospital
Condition:
PONV after thyroidectomy
Intervention:
Group U:Aprepitant combined with ondansetron
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-10
Target Sample Size: Group U:81;Group O:81;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=340967
Published by HT Digital Content Services with permission from Health...